Extensive-stage small-cell lung cancer--moving beyond response rate?
Ferraldeschi
R
R
Lorigan
P
P
D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use*; D017326:Clinical Trials, Phase III as Topic; D016371:Cranial Irradiation; D006801:Humans; D016014:Linear Models; D008175:Lung Neoplasms / Q000188:drug therapy* / Q000401:mortality / Q000532:radiotherapy; D018714:Radiotherapy, Adjuvant; D016032:Randomized Controlled Trials as Topic; D012107:Research Design; D055752:Small Cell Lung Carcinoma / Q000188:drug therapy* / Q000401:mortality / Q000532:radiotherapy; D016019:Survival Analysis; D013997:Time Factors; D016896:Treatment Outcome